Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-18-039938

Options or other derivatives

  • Director acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

THURMAN RANDY H · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-06-27 Grant or award : show line 1 in the form Stock Option (Right to Buy) +100,000 $0.88 2028-06-27 100,000 100,000 D
Loading xslF345X03/doc4.xml…